CPI-17 anticorps

N° du produit ABIN306457

Détail du produit anti-CPI-17 anticorps

Antigène: CPI-17 (PPP1R14A) (Protein Phosphatase 1, Regulatory (Inhibitor) Subunit 14A (PPP1R14A))

Reactivité: Humain

Hôte: Souris

Clonalité: Monoclonal

Conjugué: Cet anticorp CPI-17 est non-conjugé

Application: Western Blotting (WB), ELISA

Purification: The antibody was purified from mouse ascitic fluids by protein-G affinity chromatography

Immunogène: Recombinant human PPP1R14A (1-147aa), Accession / GI number: NP_150281

Clone: 4H10

Isotype: IgG2a kappa

Information d'application

Indications d'application: Recommended dilution 1:500

Restrictions: For Research Use only

Stockage

Format: Liquid

Concentration: 1mg/ml

Buffer: In Phosphate-Buffered Saline (pH7.4) with 0.1% Sodium Azide

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: -20 °C

Détails sur CPI-17

Antigène: CPI-17 (PPP1R14A) (Protein Phosphatase 1, Regulatory (Inhibitor) Subunit 14A (PPP1R14A))

Autre désignation: PPP1R14A (PPP1R14A Produits)

Synonymes: anticorps MGC81874, anticorps cpi-17, anticorps ppp1inl, anticorps CPI-17, anticorps im:7147597, anticorps ppp1r14a, anticorps zgc:110700, anticorps PPP1R14A, anticorps CPI17, anticorps PPP1INL, anticorps Cpi17, anticorps 1110001M11Rik, anticorps protein phosphatase 1 regulatory inhibitor subunit 14A L homeolog, anticorps protein phosphatase 1 regulatory inhibitor subunit 14A, anticorps protein phosphatase 1, regulatory (inhibitor) subunit 14Aa, anticorps protein phosphatase 1, regulatory (inhibitor) subunit 14A, anticorps ppp1r14a.L, anticorps ppp1r14a, anticorps ppp1r14aa, anticorps PPP1R14A, anticorps Ppp1r14a

Sujet: PPP1R14A (Protein phosphatase 1 regulatory subunit 14A) is a phosphorylation-dependent inhibitory protein for smooth muscle myosin phosphate. Myosin phosphatase can reverse MYL (myosin light chain) phosphorylation to induce a state of relaxation. However, during agonist-induced contraction at constant Ca2+ concurrent inhibition of myosin phosphatase leads to increases in MYL phosphorylation and tension. These calcium-independent increases in myosin phosphorylation and tension are termed calcium sensitization. Concentration: 1 mg/ml